» Articles » PMID: 23584067

HIV/AIDS, Comorbidity, and Alcohol: Can We Make a Difference?

Overview
Specialty Psychiatry
Date 2013 Apr 16
PMID 23584067
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol use is common among people infected with HIV and plays an important role in their health outcomes. Because alcohol use complicates HIV infection and contributes to comorbid diseases, it is important for researchers and practitioners to understand these interactions and to integrate alcohol treatment with medical management of long-term HIV infection and associated comorbidity. The Veterans Aging Cohort Study (VACS) is a large, multisite study of the effects of alcohol use on HIV outcomes in the broader context of aging. A multilevel strategy intervention trial is needed to address the many modifiable implications of alcohol consumption among those receiving treatment for HIV.

Citing Articles

Association of circulating adipokines with metabolic measures among people with HIV: Moderating effects of alcohol use.

Simon L, Lin H, Poret J, Stouwe C, Ferguson T, Welsh D Alcohol Clin Exp Res (Hoboken). 2024; 48(12):2281-2293.

PMID: 39424415 PMC: 11631649. DOI: 10.1111/acer.15464.


Reasons for not seeking alcohol treatment among a sample of Florida adults with HIV who perceived the need for treatment.

Parisi C, Siuluta N, Canidate S, Cook R, Wang Y, Widmeyer M Addict Sci Clin Pract. 2024; 19(1):71.

PMID: 39367510 PMC: 11452928. DOI: 10.1186/s13722-024-00491-5.


Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study.

Odokonyero R, Nakasujja N, Turiho A, Sanyu N, Muyindike W, Nansera D Addict Sci Clin Pract. 2024; 19(1):62.

PMID: 39223677 PMC: 11370108. DOI: 10.1186/s13722-024-00495-1.


Negative Lifestyle Factors Specific to Aging Persons Living with HIV and Multimorbidity.

Smith W J Int Assoc Provid AIDS Care. 2024; 23:23259582241245228.

PMID: 39051608 PMC: 11273731. DOI: 10.1177/23259582241245228.


Gut microbiome and cardiometabolic comorbidities in people living with HIV.

Troseid M, Nielsen S, Vujkovic-Cvijin I Microbiome. 2024; 12(1):106.

PMID: 38877521 PMC: 11177534. DOI: 10.1186/s40168-024-01815-y.


References
1.
Desquilbet L, Jacobson L, Fried L, Phair J, Jamieson B, Holloway M . HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007; 62(11):1279-86. DOI: 10.1093/gerona/62.11.1279. View

2.
Clifford P, Maisto S, Davis C . Alcohol treatment research assessment exposure subject reactivity effects: part I. Alcohol use and related consequences. J Stud Alcohol Drugs. 2007; 68(4):519-28. DOI: 10.15288/jsad.2007.68.519. View

3.
Justice A, Zingmond D, Gordon K, Fultz S, Goulet J, King Jr J . Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?. Clin Infect Dis. 2008; 47(9):1226-30. DOI: 10.1086/592302. View

4.
Freiberg M, Cheng D, Kraemer K, Saitz R, Kuller L, Samet J . The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS. 2007; 21(2):193-7. PMC: 1805683. DOI: 10.1097/QAD.0b013e3280118a0d. View

5.
. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 372(9635):293-9. PMC: 3130543. DOI: 10.1016/S0140-6736(08)61113-7. View